BRIEF: Medtide rises in Hong Kong trading debut
Peptide-focused contract research, development and manufacturing organization (CRDMO) Medtide Inc. (3880.HK) opened 4% higher in its Hong Kong trading debut on Monday, and closed up 3.76% at HK$31.75 by the…
Medtide launches IPO to bulk up its weight-loss business
The pharmaceutical services firm wants to expand production of peptides used in anti-obesity drugs, but it faces fierce competition and other business risks Key Takeaways: The global market for developing…
Recent Articles
RELATED ARTICLES
-
Medtide launches IPO to bulk up its weight-loss business
3880.HK
-
BRIEF: Zhou Liu Fu rises in Hong Kong trading debut
6168.HK
-
BRIEF: Zenergy rises 2% in Hong Kong trading debut
3677.HK
-
BRIEF: Mixue surges on Hong Kong trading debut
2097.HK
-
BRIEF: Drinda New Energy rises in Hong Kong trading debut
2865.HK 002865.SHE
